06/24/2014 | 02:12am US/Eastern Recommend: 0 Cipla Limited has tied up with Hetero Drugs to launch a drug under the Actorise brand for treatment of anaemia that is caused by chronic kidney disease. Actorise is a ... 4 Traders, 1 month ago
Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen - Pharma Letter, 1 month ago
Cipla collaborates with Hetero to launch its second biosimilar drug Darbepoetin alfa - Express Pharma, 1 month ago
3 images for "hetero drugs"
Subsidiaries of generics maker Hetero Drugs can move forward with generic versions of kidney drug PhosLo despite an ongoing lawsuit brought by patent owner Roxane Laboratories. A U.S. District Court in New Jersey denied a motion Aug. 6 from ...FDA News, 4 days ago
Research and Development, Hetero Drugs Ltd. , Plot No. B. 80 & 81, APIE, Balanagar, Hyderabad - 500018, India Org. Process Res. Dev. , Article ASAP DOI: 10.1021/op500110n Publication Date (Web): July 1, 2014 Copyright 2014 American Chemical Society ...Organic Process Research & Development, 1 month ago
India PRwire 2014-06-24 The Hetero Group, one of the largest manufacturers and suppliers of Active Pharmaceutical Ingredients (APIs) to the Indian pharmaceutical industry, today announced the launch of its first biosimilar product in India, ...BizWire Express, 1 month ago Hetero Launches Darbepoetin Alfa a Much Needed Biosimilar Anemia Treatment in India New Delhi News.Net, 2 months ago
The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a ...PharmCast, 1 month ago
By a News Reporter-Staff News Editor at AIDS Weekly -- A patent by the inventors Parthasaradhi Reddy , Bandi ( Andhra Pradesh , IN); Manohar Sharma , Vedula ( Andhra Pradesh , IN); Rathnakar Reddy , Kura ( Andhra Pradesh , IN); Madhanmohan Reddy , ...HispanicBusiness.com, 1 hour ago "Metal Nanoparticle-Pcp Complex and Manufacturing Method Therefor" in Patent Application Approval Process HispanicBusiness.com, 1 month ago
NEW HAVEN, Conn., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No. 8,809,313, covering composition-of-matter and method of ...Stockwatch, 1 day ago Achillion Pharmaceuticals, Inc. Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors BioSpace, 5 hours ago ACHILLION PHARMACEUTICALS : Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4 Traders, 1 day ago
In the third of a series of posts focusing on each of the MINT markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria. Why Nigeria? In economic terms, Nigeria is - by some margin - the smallest of the MINT ...EyeForPharma.com, 6 hours ago
The Department of Industrial Policy and Promotion (DIPP) last week once again approached the health ministry with the request to grant a compulsory license (CL) for the cancer drug, Dasatinib, on the ground that it is unaffordable to several ...PharmaBiz, 17 hours ago
HYDERABAD: It was business as usual for the IT & ITeS sector in the city on Tuesday when the government of Telangana embarked on its maiden Intensive Household Survey. Though the sector witnessed lower employee turnout, critical business operations ...New Indian Express, 18 hours ago Telangana to develop international standard Pharma city near Hyderabad PharmaBiz, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!